2010
DOI: 10.1016/j.healun.2010.03.012
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of bleomycin-induced pulmonary fibrosis through pre-treatment with collagen type V

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
25
1

Year Published

2011
2011
2016
2016

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(26 citation statements)
references
References 57 publications
0
25
1
Order By: Relevance
“…We and others (8,(12)(13)(14) previously reported that autoimmune responses to col(V) are linked to the pathogenesis of lung fibrosis. We also have previously reported IL-17-dependent anti-col(V) cellular immune responses in patients with OB with lung transplants (as measured by the trans-vivo delayed-type hypersensitivity assay); we attributed this response to be possibly due to the overabundance of induced ␣1(V) chains noted in the OB lesions (14).…”
Section: Il-17 Mediates Specific Rna and Protein Overexpression For Tmentioning
confidence: 83%
“…We and others (8,(12)(13)(14) previously reported that autoimmune responses to col(V) are linked to the pathogenesis of lung fibrosis. We also have previously reported IL-17-dependent anti-col(V) cellular immune responses in patients with OB with lung transplants (as measured by the trans-vivo delayed-type hypersensitivity assay); we attributed this response to be possibly due to the overabundance of induced ␣1(V) chains noted in the OB lesions (14).…”
Section: Il-17 Mediates Specific Rna and Protein Overexpression For Tmentioning
confidence: 83%
“…Because IL-17 induces stromal cells and monocytes to produce cytokines and promotes granulopoiesis, it has long been recognized as a possible target for therapy during lung transplantation specifically. Several studies have linked IL-17 to fibrosis in the lung in mouse models of pulmonary fibrosis as well as to idiopathic pulmonary fibrosis in humans (22,24,25). IL-17 may be a key regulator of the airway fibrotic response that drives the development of OB.…”
Section: Potential Mechanism Of Rejection Involving Il-17amentioning
confidence: 99%
“…In infection models in mice, there is considerable evidence that IL-17 and/or IL-23 are important in host responses against Klebsiella pneumoniae (Tesmer et al 2008). Furthermore, several studies have now linked IL-17 to fibrosis in the lung in mouse models of pulmonary fibrosis and idiopathic pulmonary fibrosis in humans (Braun et al 2010;Kurasawa et al 2000;Wilson et al 2010 (Figure 2). In this way, identification of distinct IL17 + T cells and even separate subpopulations is relatively simple.…”
Section: Il-17 In Lung Diseasesmentioning
confidence: 99%
“…Wegener granulomatosis (Abdulahad et al 2008), Langerhans histiocytosis (Coury et al 2008), and hypersensitivity pneumonitis (Joshi et al 2009;Simonian et al 2009) have been reported to be linked to IL-17. Pulmonary IL-17 producing γδ T cells have also been detected in response to bleomycin-induced tissue damage, a model for induced pulmonary fibrosis (Braun et al 2010). Conversely, a particular subset of γδ T cells secreting IL-17 has been shown to contribute to hyperinflammatory granulomatous disease and fatal lung tissue damage during pulmonary aspergillosis (Romani et al 2008).…”
Section: Sarcoidosis Pulmonary Fibrosis and Other Interstitial Lung mentioning
confidence: 99%